A commercial autogenous injection vaccine protects ballan wrasse (Labrus bergylta, ascanius) against aeromonas salmonicida vapA type V

• Published in: Fish & Shellfish Immunology
• Main Authors: Ramirez-Paredes, J Gustavo, Verner-Jeffreys, David, Papadopoulou, Athina, Monaghan, Sean J, Smith, Louise, Haydon, David, Wallis, Tim S, Davie, Andrew, Adams, Alexandra, Migaud, Herve
• Other Authors: Scottish Aquaculture Innovation Centre, Ridgeway Biologicals Ltd, CEFAS - Centre for Environment, Fisheries and Aquaculture Science, Institute of Aquaculture, orcid:0000-0002-7692-7756, orcid:0000-0002-9524-618X, orcid:0000-0002-5404-7512
• Format: Article in Journal/Newspaper
• Language: English
• Published: Elsevier 2020
• Subjects: ballan wrasse; vaccines; bacterial diseases; atypical Aeromonas salmonicida; cleaner fish diseases; vibriosis in wrasse; Photobacterium indicum; Ballan; Atlantic salmon
• Online Access: http://hdl.handle.net/1893/31868; https://doi.org/10.1016/j.fsi.2020.09.040; http://dspace.stir.ac.uk/bitstream/1893/31868/1/Ramirez-Paredes-etal-Accepted%20manuscript-2020.pdf

Atypical Aeromonas salmonicida (aAs) and Vibrionaceae related species are bacteria routinely recovered from diseased ballan wrasse used as cleaner fish in Atlantic salmon farming. Autogenous (i.e. farm specific inactivated) multivalent vaccines formulated from these microorganisms are widely used by...